Ceapro has developed a series of proprietary separation technologies. The first series is the source of beta glucan, the second produces colloidal oat extract. Further series of processes are in development and will be the source of materials from botanical sources other than oats.
Ceapro has developed the next generation processes for the production of oat active ingredients. As such, the new core technology is state-of-the-art and represents new, significant advances in oat processing. The active ingredients produced through the new processes are stable, highly efficacious materials that meet the rigorous demands of health science and personal-care/cosmetics industries.
|